[Recurrent Mycobacterium tuberculosis bacteremia in AIDS: subtherapeutic concentrations of antitubercular agents?]. 1994

F Dronda, and I Fernández-Martín, and F Chaves, and M González-López

UI MeSH Term Description Entries
D008297 Male Males
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D016470 Bacteremia The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion. Bacteremias
D017211 Treatment Failure A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series. Failure, Treatment,Failures, Treatment,Treatment Failures

Related Publications

F Dronda, and I Fernández-Martín, and F Chaves, and M González-López
January 1979, Vojnosanitetski pregled,
F Dronda, and I Fernández-Martín, and F Chaves, and M González-López
December 1984, Problemy tuberkuleza,
F Dronda, and I Fernández-Martín, and F Chaves, and M González-López
January 2002, Archives de l'Institut Pasteur de Madagascar,
F Dronda, and I Fernández-Martín, and F Chaves, and M González-López
July 2021, Medicinal research reviews,
F Dronda, and I Fernández-Martín, and F Chaves, and M González-López
January 1987, Farmakologiia i toksikologiia,
F Dronda, and I Fernández-Martín, and F Chaves, and M González-López
March 1966, Lekarska veda v zahranici,
F Dronda, and I Fernández-Martín, and F Chaves, and M González-López
April 2005, Bioorganic & medicinal chemistry letters,
F Dronda, and I Fernández-Martín, and F Chaves, and M González-López
February 2010, Bioorganic & medicinal chemistry,
F Dronda, and I Fernández-Martín, and F Chaves, and M González-López
December 1983, Kekkaku : [Tuberculosis],
F Dronda, and I Fernández-Martín, and F Chaves, and M González-López
December 1989, The American review of respiratory disease,
Copied contents to your clipboard!